Printer Friendly Printed from http://www.researchandmarkets.com/reports/552170 Contraception Market Report 2007 Description: The UK market for contraceptives, as evaluated in this report, comprises four main sectors: hormone-based products; barrier products; intra-uterine device (IUD) products and other methods. Hormone-based products, a publicly funded sector, is the largest sector, having overtaken barrier products, which was the largest sector in 2004. The former continues to perform well, particularly with oral contraceptives, while the latter is currently experiencing difficulties in terms of deflationary pressure on prices, which is affecting value levels. The total market was worth £164.5m in 2007, which is not a huge sum in comparison with other sectors within the pharmaceutical market. This is a low-revenue industry with a fairly saturated, slow-growing consumer base of mainly women. There is not much incentive for new product development (NPD — although it is happening) and it is telling that the most popular oral contraceptive, Microgynon, was introduced onto the UK market during the 1960s. New products — such as the combined pill Yasmin, from Schering Health and the progestogen-only pill Cerazette, from Organon — have tended to take market share from other products, rather than to stimulate the sector as a whole. Society is changing and, although levels of sexual activity have not altered much overall, people are becoming sexually active at an earlier age. This impacts on the teenage pregnancy rate, which is still the highest in Europe, and also on the occurrences of sexually transmitted infections (STIs), which are increasing at alarming rates. More education on STIs and more encouragement to use condoms, in particular, is currently a government target. This is boosting volume sales of condoms and encouraging more players to move into the sector, but revenue growth, as a whole, is currently on a downward curve within a heavily discounted market. Manufacturers of condoms have attempted to redress the loss in value through expansion of condom ranges into areas such as lubricants and massagers. In terms of the protected market, there has been a move towards long-acting reversible contraceptives (LARCs), which the National Institute for Health and Clinical Excellence (NICE) believes will be more effective methods, both in terms of contraception and cost, over the longer term. The Mirena intra-uterine system (IUS) which can last up to 5 years, has been particularly successful and there has been significant growth in the number of prescriptions issued in the UK over the period. Similarly, the contraceptive implant Implanon has become much more popular. With both these methods, women can effectively forget about contraception — certainly in terms of pregnancy — therefore, the risk of unwanted pregnancy is low. However, for the majority of young women, in particular, the pill — and mainly the combined pill — will continue to be the dominant form of contraception for some years to come. Nonetheless, for both men and women (again, particularly popular with younger adults), the condom is crucial to prevent STIs. Both of these sectors have an assured future — certainly in terms of demographics — and this stable market is firmly underpinned. Contents: Executive Summary 1. Market Definition REPORT COVERAGE MARKET SECTORS Hormone-Based Products Oral Contraceptives Depot Contraceptives Barrier Products Intra-Uterine Products Other Methods MARKET TRENDS A Steady Market With Product Development Long-Acting Reversible Contraceptives Become More Popular Condom Sales Are Falling More Contraception Needed Economic Trends Population Table 1: UK Resident Population Estimates by Sex (000), Mid-Years 2002-2006 Gross Domestic Product Table 2: UK Gross Domestic Product at Current and Annual Chain-Linked Prices (£m), 2002-2006 Inflation Table 3: UK Rate of Inflation (%), 2002-2006 Unemployment Table 4: Actual Number of Unemployed Persons in the UK (million), 2002-2006 2. Market Size The Total Market Table 5: The Total UK Contraception Market by Sector by Value (£000), Years Ending May 2003-2007 Figure 1: The Total UK Contraception Market by Sector by Value (£000), Years Ending May 2003-2007 By Market Sector Hormone-Based Products Table 6: The Hormone-Based Contraceptive Products Sector by Subsector by Value (£000 and %), Years Ending May 2003-2007 Barrier Methods Table 7: The Barrier Products Sector by Subsector by Value (£000 and %), Years Ending May 2003-2007 Intra-Uterine Products Table 8: The Intra-Uterine Products Sector by Subsector by Value (£000 and %), Years Ending May 2003-2007 Other Methods 3. Industry Background Recent History Number of Companies Employment Distribution How Robust Is The Market? Table 9: The Projected UK Female Population by Age, 1971-2021 Table 10: Average Age† of Mothers in England and Wales by Birth Order, 1971-2004 Legislation Key trade associations and industry bodies Association of British Pharmaceutical Industry British Pregnancy Advisory Service Brook Advisory Centres Department of Health The NHS Information Centre Family Planning Association Marie Stopes International National Institute for Health and Clinical Excellence National Pharmaceutical Association Royal Pharmaceutical Society of Great Britain 4. Competitor Analysis THE MARKETPLACE Market Leaders Ansell (UK) Ltd Company Structure Current and Future Development Financial Results Janssen-Cilag Ltd Company Structure Current and Future Developments Financial Results Organon Laboratories Ltd Company Structure Current and Future Developments Financial Results Pfizer Ltd Company Structure Current and Future Developments Financial Results Schering Health Care Ltd Company Structure Current and Future Developments Financial Results SSL International PLC Company Structure Current and Future Developments Financial Results Other Companies Boots and Superdrug Church & Dwight UK Ltd Condomi Health UK Ltd The Female Health Company (UK) PLC FCUK Sexual Health Group PLC Wyeth Europa Ltd Marketing Activity Main Media Advertising Expenditure Table 11: Main Media Advertising Expenditure by Type and Brand, Years Ending March 2006 and 2007 Exhibitions and Trade Shows 5. Strengths, Weaknesses, Opportunities and Threats 6. Buying Behaviour INTRODUCTION Contraceptive Use Table 12: Use of Contraception by Women Aged 16 to 49 in Great Britain by Type (%), 2001/2002-2005/2006 CONTRACEPTIVE USE BY AGE GROUP Table 13: Use of Contraception by Women in Great Britain by Age (%), 2005/2006 GP Prescriptions Table 14: Prescription Cost Analysis of Contraceptives by Type (£m), 2002/2003 to 2006/2007 Family Planning Table 15: Family Planning Services used by Women in Great Britain Aged 16 to 49 (%), 2001/2002-2005/2006 Reasons for Using Condoms Table 16: Reasons for Using a Condom in Great Britain by Sex (%), 2001/2002 to 2005/2006 Demographics of Condom Purchasing Table 17: Purchase of Condoms (% of adults), 2006 Frequent Purchasers of Condoms Table 18: Heavy Purchasers† of Condoms (% of adults), 2006 7. Current Issues Levels of Sexual Activity Table 19: Number of Legal Abortions in England and Wales, 1971-2001 Figure 2: Number of Legal Abortions in England and Wales, 1971-2001 Sexually transmitted Infections Government Response LARCs Targeting Young People 8. The Global Market Introduction Market Size New Products Developing Markets Research and Development 9. Forecasts Introduction Economic Forecasts Population Table 20: Forecast UK Resident Population by Sex (000), Mid-Years 2007-2011 Gross Domestic Product Table 21: Forecast UK Growth in Gross Domestic Product in Real Terms (%), 2007-2011 Inflation Table 22: Forecast UK Rate of Inflation (%), 2007-2011 Unemployment Table 23: Forecast Actual Number of Unemployed Persons in the UK (million), 2007-2011 Forecasts 2008 to 2012 Table 24: The Forecast UK Contraception Market by Sector by Value (£m), Years Ending May 2008-2012 Figure 3: The Forecast UK Contraception Market by Sector by Value (£m), Years Ending May 2008-2012 Market Growth Figure 4: The Total UK Contraception Market by Value (£m), Years Ending May 2003-2012 Future Trends New Product Development Increasing Awareness Social Trends Over the Counter 10. Company Profiles Ansell (uk) Ltd Janssen-cilag Ltd Organon Laboratories Ltd Pfizer Ltd Schering Health Care Ltd SSL International Plc 11. Consumer Confidence METHODOLOGY KEY FINDINGS THIS QUARTER THE WILLINGNESS TO BORROW Confidence Improves Table A: The Average Amount Consumers Are Willing to Borrow in Order to Purchase Expensive Items at Current and Constant November 2004 Prices (£ and £bn), February 2006-2007 Willingness to Borrow Slips Slightly Table B: The Number of Adults Willing to Borrow in Order to Purchase Expensive Items (000 and %), February 2006-2007 SPENDING FROM SAVINGS Slight Increase in Spending from Savings Table C: The Average Amount Consumers Are Willing to Spend from Savings in Order to Purchase Expensive Items at Current and Constant November 2004 Prices (£ and £bn), February 2006-2007 Saving Grows in Relative Importance Table D: The Average Amounts Adults Are Confident Spending to Purchase Expensive Items (£ and %), February 2006-2007 12. Further Sources Associations General Sources Government Publications Other Sources Bisnode Sources Companies Mentioned - Ansell (uk) Ltd - Janssen-cilag Ltd - Organon Laboratories Ltd - Pfizer Ltd - Schering Health Care Ltd - SSL International Plc - Association of British Pharmaceutical Industry - British Pregnancy Advisory Service - Brook Advisory Centres - Department of Health - The NHS Information Centre - Family Planning Association - Marie Stopes International - National Institute for Health and Clinical Excellence - National Pharmaceutical Association - Royal Pharmaceutical Society of Great Britain - Boots and Superdrug - Church & Dwight UK Ltd - Condomi Health UK Ltd - The Female Health Company (UK) PLC - FCUK - Sexual Health Group PLC - Wyeth Europa Ltd Ordering: Order Online - visit http://www.researchandmarkets.com/reports/552170 Order by Fax - using the order form below Order By Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Printed 30/08/2008 15:43:56 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com Order information Please verify that the product information is correct and select the format you require. Product Name: Contraception Market Report 2007 Web Address: http://www.researchandmarkets.com/reports/552170 Office Code: OCHGMLLSPWV Report formats Please enter the quantity of the report format you require. Format Quantity Price Electronic (PDF) - Single User €774.00 Hard Copy €950.00 + EUR€ 50.00 Shipping/Handling * * Shipping/Handling is only charged once per order. Contact information Please enter all the information below in BLOCK CAPITALS. First Name:   Last Name:   Email Address: Job Title: Organisation: Address: City: Postal/Zip Code: Country: Phone Number: Fax Number: Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World Page 2 of 2 Printed 30/08/2008 15:43:56 Payment information Please indicate the payment method you would like to use by selecting the appropriate box.  Pay by Credit Card: American Express Diners Club Master Card Visa Cardholder Name: Expiry Date: / Card Number: CVV Security Code: Issue Date: /   (Diners Club only)  Pay by Check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.  Pay by Wire Transfer: Please transfer funds to: Account number: 83313083 Sort code: 98-53-30 Swift code: ULSBIE2D IBAN number: IE78ULSB98533083313083 Bank Address: Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World